Cargando…

Risk Factors for SARS-CoV-2 Infection and Severe Outcomes Among People With Human Immunodeficiency Virus: Cohort Study

BACKGROUND: Studies on COVID-19 in people with HIV (PWH) have had limitations. Further investigations on risk factors and outcomes of SARS-CoV-2 infection among PWH are needed. METHODS: This retrospective cohort study leveraged the national OPTUM COVID-19 data set to investigate factors associated w...

Descripción completa

Detalles Bibliográficos
Autores principales: Hanna, John J, Geresu, Liyu B, Diaz, Marlon I, Ho, Milan, Casazza, Julia A, Pickering, Madison A, Lanier, Heather D, Radunsky, Alexander P, Cooper, Lauren N, Saleh, Sameh N, Bedimo, Roger J, Most, Zachary M, Perl, Trish M, Lehmann, Christoph U, Turer, Robert W, Chow, Jeremy Y, Medford, Richard J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10416813/
https://www.ncbi.nlm.nih.gov/pubmed/37577110
http://dx.doi.org/10.1093/ofid/ofad400
_version_ 1785087866376814592
author Hanna, John J
Geresu, Liyu B
Diaz, Marlon I
Ho, Milan
Casazza, Julia A
Pickering, Madison A
Lanier, Heather D
Radunsky, Alexander P
Cooper, Lauren N
Saleh, Sameh N
Bedimo, Roger J
Most, Zachary M
Perl, Trish M
Lehmann, Christoph U
Turer, Robert W
Chow, Jeremy Y
Medford, Richard J
author_facet Hanna, John J
Geresu, Liyu B
Diaz, Marlon I
Ho, Milan
Casazza, Julia A
Pickering, Madison A
Lanier, Heather D
Radunsky, Alexander P
Cooper, Lauren N
Saleh, Sameh N
Bedimo, Roger J
Most, Zachary M
Perl, Trish M
Lehmann, Christoph U
Turer, Robert W
Chow, Jeremy Y
Medford, Richard J
author_sort Hanna, John J
collection PubMed
description BACKGROUND: Studies on COVID-19 in people with HIV (PWH) have had limitations. Further investigations on risk factors and outcomes of SARS-CoV-2 infection among PWH are needed. METHODS: This retrospective cohort study leveraged the national OPTUM COVID-19 data set to investigate factors associated with SARS-CoV-2 positivity among PWH and risk factors for severe outcomes, including hospitalization, intensive care unit stays, and death. A subset analysis was conducted to examine HIV-specific variables. Multiple variable logistic regression was used to adjust for covariates. RESULTS: Of 43 173 PWH included in this study, 6472 had a positive SARS-CoV-2 result based on a polymerase chain reaction test or antigen test. For PWH with SARS-CoV-2 positivity, higher odds were found for those who were younger (18–49 years), Hispanic White, African American, from the US South, uninsured, and a noncurrent smoker and had a higher body mass index and higher Charlson Comorbidity Index. For PWH with severe outcomes, higher odds were identified for those who were SARS-CoV-2 positive, older, from the US South, receiving Medicaid/Medicare or uninsured, a current smoker, and underweight and had a higher Charlson Comorbidity Index. In a subset analysis including PWH with HIV care variables (n = 5098), those with unsuppressed HIV viral load, a low CD4 count, and no antiretroviral therapy had higher odds of severe outcomes. CONCLUSIONS: This large US study found significant ethnic, racial, and geographic differences in SARS-CoV-2 infection among PWH. Chronic comorbidities, older age, lower body mass index, and smoking were associated with severe outcomes among PWH during the COVID-19 pandemic. SARS-CoV-2 infection was associated with severe outcomes, but once we adjusted for HIV care variables, SARS-CoV-2 was no longer significant; however, low CD4 count, high viral load, and lack of antiretroviral therapy had higher odds of severe outcomes.
format Online
Article
Text
id pubmed-10416813
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-104168132023-08-12 Risk Factors for SARS-CoV-2 Infection and Severe Outcomes Among People With Human Immunodeficiency Virus: Cohort Study Hanna, John J Geresu, Liyu B Diaz, Marlon I Ho, Milan Casazza, Julia A Pickering, Madison A Lanier, Heather D Radunsky, Alexander P Cooper, Lauren N Saleh, Sameh N Bedimo, Roger J Most, Zachary M Perl, Trish M Lehmann, Christoph U Turer, Robert W Chow, Jeremy Y Medford, Richard J Open Forum Infect Dis Major Article BACKGROUND: Studies on COVID-19 in people with HIV (PWH) have had limitations. Further investigations on risk factors and outcomes of SARS-CoV-2 infection among PWH are needed. METHODS: This retrospective cohort study leveraged the national OPTUM COVID-19 data set to investigate factors associated with SARS-CoV-2 positivity among PWH and risk factors for severe outcomes, including hospitalization, intensive care unit stays, and death. A subset analysis was conducted to examine HIV-specific variables. Multiple variable logistic regression was used to adjust for covariates. RESULTS: Of 43 173 PWH included in this study, 6472 had a positive SARS-CoV-2 result based on a polymerase chain reaction test or antigen test. For PWH with SARS-CoV-2 positivity, higher odds were found for those who were younger (18–49 years), Hispanic White, African American, from the US South, uninsured, and a noncurrent smoker and had a higher body mass index and higher Charlson Comorbidity Index. For PWH with severe outcomes, higher odds were identified for those who were SARS-CoV-2 positive, older, from the US South, receiving Medicaid/Medicare or uninsured, a current smoker, and underweight and had a higher Charlson Comorbidity Index. In a subset analysis including PWH with HIV care variables (n = 5098), those with unsuppressed HIV viral load, a low CD4 count, and no antiretroviral therapy had higher odds of severe outcomes. CONCLUSIONS: This large US study found significant ethnic, racial, and geographic differences in SARS-CoV-2 infection among PWH. Chronic comorbidities, older age, lower body mass index, and smoking were associated with severe outcomes among PWH during the COVID-19 pandemic. SARS-CoV-2 infection was associated with severe outcomes, but once we adjusted for HIV care variables, SARS-CoV-2 was no longer significant; however, low CD4 count, high viral load, and lack of antiretroviral therapy had higher odds of severe outcomes. Oxford University Press 2023-07-24 /pmc/articles/PMC10416813/ /pubmed/37577110 http://dx.doi.org/10.1093/ofid/ofad400 Text en © The Author(s) 2023. Published by Oxford University Press on behalf of Infectious Diseases Society of America. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Major Article
Hanna, John J
Geresu, Liyu B
Diaz, Marlon I
Ho, Milan
Casazza, Julia A
Pickering, Madison A
Lanier, Heather D
Radunsky, Alexander P
Cooper, Lauren N
Saleh, Sameh N
Bedimo, Roger J
Most, Zachary M
Perl, Trish M
Lehmann, Christoph U
Turer, Robert W
Chow, Jeremy Y
Medford, Richard J
Risk Factors for SARS-CoV-2 Infection and Severe Outcomes Among People With Human Immunodeficiency Virus: Cohort Study
title Risk Factors for SARS-CoV-2 Infection and Severe Outcomes Among People With Human Immunodeficiency Virus: Cohort Study
title_full Risk Factors for SARS-CoV-2 Infection and Severe Outcomes Among People With Human Immunodeficiency Virus: Cohort Study
title_fullStr Risk Factors for SARS-CoV-2 Infection and Severe Outcomes Among People With Human Immunodeficiency Virus: Cohort Study
title_full_unstemmed Risk Factors for SARS-CoV-2 Infection and Severe Outcomes Among People With Human Immunodeficiency Virus: Cohort Study
title_short Risk Factors for SARS-CoV-2 Infection and Severe Outcomes Among People With Human Immunodeficiency Virus: Cohort Study
title_sort risk factors for sars-cov-2 infection and severe outcomes among people with human immunodeficiency virus: cohort study
topic Major Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10416813/
https://www.ncbi.nlm.nih.gov/pubmed/37577110
http://dx.doi.org/10.1093/ofid/ofad400
work_keys_str_mv AT hannajohnj riskfactorsforsarscov2infectionandsevereoutcomesamongpeoplewithhumanimmunodeficiencyviruscohortstudy
AT geresuliyub riskfactorsforsarscov2infectionandsevereoutcomesamongpeoplewithhumanimmunodeficiencyviruscohortstudy
AT diazmarloni riskfactorsforsarscov2infectionandsevereoutcomesamongpeoplewithhumanimmunodeficiencyviruscohortstudy
AT homilan riskfactorsforsarscov2infectionandsevereoutcomesamongpeoplewithhumanimmunodeficiencyviruscohortstudy
AT casazzajuliaa riskfactorsforsarscov2infectionandsevereoutcomesamongpeoplewithhumanimmunodeficiencyviruscohortstudy
AT pickeringmadisona riskfactorsforsarscov2infectionandsevereoutcomesamongpeoplewithhumanimmunodeficiencyviruscohortstudy
AT lanierheatherd riskfactorsforsarscov2infectionandsevereoutcomesamongpeoplewithhumanimmunodeficiencyviruscohortstudy
AT radunskyalexanderp riskfactorsforsarscov2infectionandsevereoutcomesamongpeoplewithhumanimmunodeficiencyviruscohortstudy
AT cooperlaurenn riskfactorsforsarscov2infectionandsevereoutcomesamongpeoplewithhumanimmunodeficiencyviruscohortstudy
AT salehsamehn riskfactorsforsarscov2infectionandsevereoutcomesamongpeoplewithhumanimmunodeficiencyviruscohortstudy
AT bedimorogerj riskfactorsforsarscov2infectionandsevereoutcomesamongpeoplewithhumanimmunodeficiencyviruscohortstudy
AT mostzacharym riskfactorsforsarscov2infectionandsevereoutcomesamongpeoplewithhumanimmunodeficiencyviruscohortstudy
AT perltrishm riskfactorsforsarscov2infectionandsevereoutcomesamongpeoplewithhumanimmunodeficiencyviruscohortstudy
AT lehmannchristophu riskfactorsforsarscov2infectionandsevereoutcomesamongpeoplewithhumanimmunodeficiencyviruscohortstudy
AT turerrobertw riskfactorsforsarscov2infectionandsevereoutcomesamongpeoplewithhumanimmunodeficiencyviruscohortstudy
AT chowjeremyy riskfactorsforsarscov2infectionandsevereoutcomesamongpeoplewithhumanimmunodeficiencyviruscohortstudy
AT medfordrichardj riskfactorsforsarscov2infectionandsevereoutcomesamongpeoplewithhumanimmunodeficiencyviruscohortstudy